HIGHLIGHTS
- who: Lupus nephropathy and colleagues from the Universidad Simu00f3n Bolu00edvar, Barranquilla, Colombia have published the paper: Inhibidores de SGLT-2 en Nefropatu00eda Lu00fapica. Podria considerarse una intervenciu00f3n de Nefroprotecciu00f3n, in the Journal: (JOURNAL)
SUMMARY
Systemic lupus erythematosus (SLE) is a chronic autoimmune rheumatologic disorder. The usual treatment of lupus nephritis includes nephroprotective drugs, immunosuppressants, and immunomodulators. Experimental studies of lupus nephritis mentioned the expression of SGLT-2; therefore, this Article aims to make an updated review of the evidence on the use of SGLT-2 inhibitors in patients with nephritis. Este es un . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.